Masimo (MASI) Net Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 21.24% |
| Sep 27, 2025 | -45.58% |
| Jun 28, 2025 | -11.70% |
| Mar 29, 2025 | -30.05% |
| Dec 28, 2024 | 6.32% |
| Sep 28, 2024 | -15.62% |
| Jun 29, 2024 | -35.44% |
| Mar 30, 2024 | 14.94% |
| Dec 30, 2023 | -34.69% |
| Sep 30, 2023 | -16.64% |
| Jul 1, 2023 | -15.55% |
| Apr 1, 2023 | -23.25% |
| Dec 31, 2022 | -27.54% |
| Oct 1, 2022 | 22.28% |
| Jul 2, 2022 | -105.77% |
| Apr 2, 2022 | -21.41% |
| Jan 1, 2022 | -81.38% |
| Apr 3, 2021 | -73.08% |
| Mar 28, 2020 | 60.73% |
| Sep 28, 2019 | 35.49% |
| Jun 29, 2019 | 26.01% |
| Mar 30, 2019 | -52.69% |
| Dec 29, 2018 | 72.08% |
| Sep 29, 2018 | 38.21% |
| Jun 30, 2018 | 85.12% |
| Mar 31, 2018 | 40.49% |
| Dec 30, 2017 | 20.98% |
| Sep 30, 2017 | -38.25% |
| Jul 1, 2017 | -12.11% |
| Apr 1, 2017 | 125.60% |
| Dec 31, 2016 | 73.99% |
| Oct 1, 2016 | -10.30% |
| Jul 2, 2016 | -25.84% |
| Apr 2, 2016 | -17.20% |
| Jan 2, 2016 | 18.88% |
| Apr 4, 2015 | 15.29% |
| Sep 27, 2014 | 5.42% |